BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12871975)

  • 1. Smurf1 facilitates myogenic differentiation and antagonizes the bone morphogenetic protein-2-induced osteoblast conversion by targeting Smad5 for degradation.
    Ying SX; Hussain ZJ; Zhang YE
    J Biol Chem; 2003 Oct; 278(40):39029-36. PubMed ID: 12871975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
    Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
    J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation.
    Zhao M; Qiao M; Oyajobi BO; Mundy GR; Chen D
    J Biol Chem; 2003 Jul; 278(30):27939-44. PubMed ID: 12738770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation.
    Zhu H; Kavsak P; Abdollah S; Wrana JL; Thomsen GH
    Nature; 1999 Aug; 400(6745):687-93. PubMed ID: 10458166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription.
    Ghosh-Choudhury N; Abboud SL; Nishimura R; Celeste A; Mahimainathan L; Choudhury GG
    J Biol Chem; 2002 Sep; 277(36):33361-8. PubMed ID: 12084724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.
    Kurisaki K; Kurisaki A; Valcourt U; Terentiev AA; Pardali K; Ten Dijke P; Heldin CH; Ericsson J; Moustakas A
    Mol Cell Biol; 2003 Jul; 23(13):4494-510. PubMed ID: 12808092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo.
    Zhao M; Qiao M; Harris SE; Oyajobi BO; Mundy GR; Chen D
    J Biol Chem; 2004 Mar; 279(13):12854-9. PubMed ID: 14701828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12.
    Lee KS; Kim HJ; Li QL; Chi XZ; Ueta C; Komori T; Wozney JM; Kim EG; Choi JY; Ryoo HM; Bae SC
    Mol Cell Biol; 2000 Dec; 20(23):8783-92. PubMed ID: 11073979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12.
    Nishimura R; Kato Y; Chen D; Harris SE; Mundy GR; Yoneda T
    J Biol Chem; 1998 Jan; 273(4):1872-9. PubMed ID: 9442019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts.
    Yamamoto N; Akiyama S; Katagiri T; Namiki M; Kurokawa T; Suda T
    Biochem Biophys Res Commun; 1997 Sep; 238(2):574-80. PubMed ID: 9299554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of tumor necrosis factor-mediated apoptosis by nuclear factor kappaB-independent bone morphogenetic protein/Smad signaling.
    Chen S; Guttridge DC; Tang E; Shi S; Guan K; Wang CY
    J Biol Chem; 2001 Oct; 276(42):39259-63. PubMed ID: 11500509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5.
    Nishimura R; Hata K; Harris SE; Ikeda F; Yoneda T
    Bone; 2002 Aug; 31(2):303-12. PubMed ID: 12151083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
    Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
    J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression.
    Lee MH; Kim YJ; Kim HJ; Park HD; Kang AR; Kyung HM; Sung JH; Wozney JM; Kim HJ; Ryoo HM
    J Biol Chem; 2003 Sep; 278(36):34387-94. PubMed ID: 12815054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of BMPs/Smad signaling pathway in mechanical response in osteoblasts.
    Wang L; Zhang X; Guo Y; Chen X; Li R; Liu L; Shi C; Guo C; Zhang Y
    Cell Physiol Biochem; 2010; 26(6):1093-102. PubMed ID: 21220940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells.
    Peng Y; Kang Q; Luo Q; Jiang W; Si W; Liu BA; Luu HH; Park JK; Li X; Luo J; Montag AG; Haydon RC; He TC
    J Biol Chem; 2004 Jul; 279(31):32941-9. PubMed ID: 15161906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
    Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
    J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular signaling of osteogenic protein-1 through Smad5 activation.
    Tamaki K; Souchelnytskyi S; Itoh S; Nakao A; Sampath K; Heldin CH; ten Dijke P
    J Cell Physiol; 1998 Nov; 177(2):355-63. PubMed ID: 9766532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1).
    Pardali K; Kowanetz M; Heldin CH; Moustakas A
    J Cell Physiol; 2005 Jul; 204(1):260-72. PubMed ID: 15690394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.